You are herePune



Firake Bhushan M.1, Pandagale Sagar J.2, Firke Sandip D.3, Palshikar Gautam S.4
1Department of Pharmaceutical Chemistry, JSPM’s Jayawantrao Sawant College of Pharmacy and Research, Hadapsar, Pune
2Department of Pharmaceutical Analysis, JSPM’s Jayawantrao Sawant College of Pharmacy and Research, Hadapsar, Pune
3Department of Pharmaceutical Chemistry, SES’s R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur
4Department of Pharmacognosy, JSPM’s Jayawantrao Sawant College of Pharmacy and Research, Hadapsar, Pune

Epilepsy is one of the most serious disorders of the brain, affecting about 50 million people worldwide. Epilepsy leads to multiple interacting medical, psychological, economic and social consequences. Successful seizure control is very important in decreasing the psychosocial and economic costs of epilepsy. Yet, most therapies didn’t completely improve patients for numerous reasons. The most effective antiepileptic drugs (AEDs) include phenytoin, carbamazepine, valproic acid, phenobarbital, and primidone. Of the older AEDs, carbamazepine and valproic acid together bring a threat of hepatic toxicity and have been associated with fetal anomalies. Carbamazepine and phenytoin aggravate hypersensitivity reactions in a significant number of patients, and phenytoin is associated with chronic adverse events (AEs). Phenytoin, carbamazepine, phenobarbital, and primidone are hepatic enzyme inducers. Valproic acid, on the contrary, is a powerful hepatic inhibitor.

The newer agents have fewer drug interactions and slight, if at all, effect on the CYP450 enzyme system and other metabolic pathways. One of these new agents was gabapentin (GBP). GBP, the new antiepileptic drug (AED) has a broad spectrum of anti-seizure effects, less adverse effects and less drug interaction. GBP has since achieved international acknowledgment, not for its antiepileptic properties, but also its effectiveness in the managing of acute and chronic pain syndromes, especially neuropathic pain. It is prescribed as an add-on medication for the treatment of patients aged >12 years with partial and secondary generalized tonic-clonic seizures and for children aged 3 to 12 years with partial seizures. It has been used for monotherapy in adults in 38 countries. Gabapentin is regarded as safe and tolerable with a promising pharmacokinetic profile and an extensive therapeutic index.

The present article reviews the available information that dealing with the long-standing efficiency and safety of gabapentin in the treatment of patients with epilepsy.

Opportunity in Govt. Research Scheme for M.Pharm/M.Sc Fresh or exp Indian or NRI Candidates - multiple fellowships

Department of health research (DHR) has a scheme to provide advanced training in India and abroad to medical and health   research personnel in cutting edge research areas concerning medicine and health to create trained  human  resource for carrying out research activities. The scheme has following components: 
1. Long  Term  Fellowship  for  6-12  months  in  identified  areas  from regular faculty of Medical Colleges/Universities/Research Institutes for training in Foreign/Indian Institutes (Age: upto 45 years) 

Drug Inspector Question Paper 2015



1. Zero order kinetics is seen in all except:
(a) Salicylates
(b) Barbiturates
(c) Phenytoin
(d) Ethanol

2. Which one of the following is not a prodrug?
(a) Chloral hydrate
(b) Diazepam
(c) Enalapril
(d) Oxcarbazepine

Joint CSIR-UGC Test for Junior Research Fellowship And Eligibility for Lectureship

The CSIR and UGC provide CSIR/UGC Research Fellowship to bright young men and women for training in methods of research under expert guidance of faculty members/scientists working in University Departments/ National Laboratories and Institutions in various fields of Science & Technology. The CSIR/UGC fellowships are tenable in Universities/IITs/Post Graduate Colleges/Govt. Research Establishments including those of the CSIR, Academy of Scientific & Innovative Research (AcSIR), Research & Development establishments of recognized public or private sector industrial firms and other recognized institutions. However, CSIR reserves right to determine the place best suited to provide necessary facilities in the area of science and technology in which the awardees are to specialize. The CSIR/UGC Fellowship is tenable in India. Only bonafide Indian citizen residing in India are eligible for the award of Junior Research fellowships. The program is aimed at National Science & Technology Human Resource Development.

Post: Junior Research Fellowship And Eligibility for Lectureship

Opening for Project Fellow (PA II) in National Chemical Laboratory

Applications are invited on plain paper for filling up of position of Project Fellow (PA II) on a purely temporary basis, in the prescribed proforma. The details of the Sponsored Project under which engagement is proposed to be made is as under :

Post: Project Fellow (PA II) - One

Walk in interview for Pharmacist, Health & Malaria Inspector in Railway Hospital

Applicants are invited along with the applications for filling up of Para-Medical staff in Group-C category on CONTRACT basis up to 30/06/2016 or till the availbility of Regular candidate through RRB which ever is earlier.

Post: Pharmacist, Health & Malaria Inspector

Global Green Nanotechnology Conclave (GiGaNTiC 2015)

Global Green Nanotechnology Conclave (GiGaNTiC 2015)
Focus areas are: 1) Pharma & Biotechnology; 2) Advanced materials for various industrial applications theme
"Fostering Innovation to build core competency and provide market leadership for sustainable growth”

Great platform to showcase and commercialize your products/services to MD & CEOs of the various companies, technologists, scientists, academicians, policy makers and end-users.

Dear Sir/Madam,

I’m pleased to inform you that, CII-Gujarat Centre of Excellence in Nanotechnology is organizing “Global Green Nanotechnology Conclave (GiGaNTiC 2015)” with the theme “Fostering Innovation to build core competency and provide market leadership for sustainable growth” on 6-7th August, 2015 atAhmedabad, India. Department of Science & Technology (DST) Government of India, Department of Electronics & InformationTechnology (DeitY) and Gujarat Council on Science and Technology(GUJCOST), DST, Government of Gujarat have kindly agreed to support CII in organizing the Nanotechnology Conclave. This conclave will be having Conference + Exhibition + Panel Discussion + Workshop.

Opportunities for business networking: Some of the confirmed participation from Tata Chemicals, TCS, Cadila Pharma, Zydus Cadila, Sun Pharma, Dr. Reddy’s, Torrent Pharma, Lupin, Elecon Ltd., Arvind Ltd., Admat Innovations, Zydex Industries, USV Ltd., I-Can-Nano, Aarshadhaatu, Nualgi Nanobiotech, Advance solutions, Bharat Petroleum, Jay Chemicals, Asian Granito, Continental Carbon, Eesavyasa Technologies, Ants Ceramics, InventyS, Fujifilm Sonosite, etc.

Opportunities to connect with R&D institutes, Universities & Labs for collaborative research & development projects.

I am writing to request your kind participation and also nominate colleagues from your organization at this conference of national importance by filling up the registration form. Kindly send the completed registration form along with payment by fax / courier / email to us. Detailed brochure isattached herewith for your kind reference. I am sure that your presence and participation would add great value to the conclave.

For Delegates from Universities / Academics, we are offering 1+1 free for delegate registration based on first come first serve .  Look forward for your kind confirmation.

For more information, kindly click on the following link:

Please feel free to call me if you have any query.

Kindly contact us for group discount

Session Details

Day 1: 6th August, 2015

Day 2: 7th August, 2015

1000 – 1130 Hrs: Inauguration Session

1150 – 1310 Hrs: Plenary Session-1 (Designing of Green Nanomaterials for New-age Industries: Its Easier thanYouThink)

1400 – 1530 Hrs: Plenary Session 2 (Nanotechnology applications in Healthcare)

1600 – 1730 Hrs: Plenary Session 3 (The Pathway to commercialization of Nanomedicines: Pre-clinical,clinical,quality, scale-up, manufacturing and regulatory dossiers and approvals)

1000 – 1130 Hrs: Plenary Session 4: Fabrication and characterization of advanced nanomaterials forvariousIndustrial applications - I

1150 – 1310 Hrs: Plenary Session 5: Fabrication and characterization of advanced nanomaterials forvariousIndustrial applications – II

1400 – 1530 Hrs: Panel Discussion (Theme: Nanotechnology for providing market leadershipandachieving sustainable market growth: Opportunities, challenges, policies and the way forward)

1600 – 1730 Hrs: Workshop on Advanced characterization techniques for nanomaterials

Confirmed / Invited speakers

Shri Saurabhbhai Patel; Minister-Industries & Mines, Govt. of Gujarat

Mr. R Mukundan; Managing Director, Tata Chemicals Ltd

Dr. Y. S. Rajan; Hon Distinguished Professor, ISRO

Dr. G Sundararajan; Director, ARCI, Hyderabad

Dr. Praveer Asthana; Mission Director, Nanomission, DST, GOI

Dr. M O Garg; Director General, CSIR, New Delhi

Dr. G N Singh; DCGI, New Delhi

Dr. B. S. Chakraborty; Senior vice president & Chair, Cadila Pharma

Professor Harish Padh; Vice Chancellor, Sardar Patel University

Dr. R. P. Singh; Chair Nanotechnology, Amity University

Dr. Mukul Jain; Senior Vice President, Zydus Cadila

Dr. Ajay Khopade; Vice-President, SPARC, Sun Pharmaceuticals Ltd.

Professor Alok Dhawan; Director, Institute of Life Sciences, Ahmedabad Univ.

Dr. H. Purushotham; Chairman & Managing Director, NRDC

Dr. Arup Chatterjee; CEO, I-Can Nano

Mr. R B Karthik Aamanchi; Executive Director, Aarshadhaatu Green Nanotechnologies

MrManoj Bhataria; ‎Head - AdvanceMachines, Inventys Research Company Pvt Ltd.

Dr. Ajay Ranka; CEO, Zydex Industries Ltd., Vadodara, Gujarat.

Professor Ashok K Ganguli; Director, INST, Mohali

Professor Ashok M. Raichur; Indian Institute of Science, Bangalore

Mr. D. P. Chakravarthy; MD, Eesavyasa Technologies Pvt. Ltd.

Mr. Sampath Kumar Thothathri; CEO, Nualgi Nanobiotech

Mr. Mihir Joshi; CEO, Gujarat Venture Financial Ltd.

Mr. P Siva Prasad; CEO, Analytical Technologies

For further details, Please contact:
Gaurang Patel
Centre of Excellence in Nanotechnology (CoE-NT)
Confederation of Indian Industry, CII House, GulbaiTekra Road, Near Panchvati, Ahmedabad - 380 006
Contact No.: 08460464349

Career as Medical Representatives & Area Manager at Heal-Thy Pharmaceuticals

Heal- Thy Pharmaceuticals is an upcoming pharma company in Pune. The company is involved in domestic and international sales. The company specializes in gynecology range of products.

Post: Medical Representatives & Area Manager

Job Description:
Looking for MR and Area Managers to promote gynecology products in the region of pune and surrounding.


Subscribe to RSS headline updates from: